{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:09:45Z","timestamp":1793185785887,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["P50-AG16574"],"award-info":[{"award-number":["P50-AG16574"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["U01 AG06786"],"award-info":[{"award-number":["U01 AG06786"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["R01-AG15866"],"award-info":[{"award-number":["R01-AG15866"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["U24-AG26395"],"award-info":[{"award-number":["U24-AG26395"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["R01-AG011378"],"award-info":[{"award-number":["R01-AG011378"]}]},{"name":"NIH","award":["RO1-AG037551"],"award-info":[{"award-number":["RO1-AG037551"]}]},{"name":"NIH","award":["U01-HL096917"],"award-info":[{"award-number":["U01-HL096917"]}]},{"name":"NIH","award":["U01-AG032438"],"award-info":[{"award-number":["U01-AG032438"]}]},{"name":"NIH","award":["U01-AG024904"],"award-info":[{"award-number":["U01-AG024904"]}]},{"name":"NIH","award":["R01-AG11378"],"award-info":[{"award-number":["R01-AG11378"]}]},{"name":"NIH","award":["U01\u201324904"],"award-info":[{"award-number":["U01\u201324904"]}]},{"name":"NIH","award":["P01AG017216"],"award-info":[{"award-number":["P01AG017216"]}]},{"name":"NIH","award":["P50-NS072187"],"award-info":[{"award-number":["P50-NS072187"]}]},{"name":"NIH","award":["R01-AG040042"],"award-info":[{"award-number":["R01-AG040042"]}]},{"name":"NIH","award":["R21 NS066147"],"award-info":[{"award-number":["R21 NS066147"]}]},{"name":"NIH","award":["P50 AG44170"],"award-info":[{"award-number":["P50 AG44170"]}]},{"name":"NIH","award":["K23 AG030935"],"award-info":[{"award-number":["K23 AG030935"]}]},{"name":"NIH","award":["C06 RR018898"],"award-info":[{"award-number":["C06 RR018898"]}]},{"name":"Alexander Family Alzheimer's Disease Research Professorship"},{"name":"Mangurian Foundation"},{"name":"Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.neurobiolaging.2014.01.001","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T07:15:19Z","timestamp":1389165319000},"page":"1483-1490","source":"Crossref","is-referenced-by-count":33,"title":["Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies"],"prefix":"10.1016","volume":"35","author":[{"given":"Jonathan","family":"Graff-Radford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley F.","family":"Boeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7379-2545","authenticated-orcid":false,"given":"Melissa E.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanis J.","family":"Ferman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirubol","family":"Tosakulwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G.","family":"Lesnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandie","family":"Maroney-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Senjem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Gunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Knopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Clifford R.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejal","family":"Kantarci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib1","series-title":"International Classification of Sleep Disorders\u20142: Diagnostic and Coding Manual","year":"2005"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1212\/WNL.56.6.737","article-title":"Decreased glutamate\u00a0+ glutamine in Alzheimer's disease detected in\u00a0vivo with (1)H-MRS at 0.5 T","volume":"56","author":"Antuono","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib3","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.pnpbp.2007.12.011","article-title":"High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease","volume":"32","author":"Bartha","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib4","first-page":"1619","article-title":"Inflammatory CNS demyelination: histopathologic correlation with in\u00a0vivo quantitative proton MR spectroscopy","volume":"20","author":"Bitsch","year":"1999","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1212\/01.WNL.0000149638.45635.FF","article-title":"Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients","volume":"64","author":"Chao","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.brainres.2004.02.079","article-title":"Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile","volume":"1012","author":"Dedeoglu","year":"2004","journal-title":"Brain res."},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib7","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/brain\/awf278","article-title":"Magnetic resonance spectroscopy and cognitive function in healthy elderly men","volume":"125","author":"Ferguson","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1212\/WNL.62.2.181","article-title":"DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging","volume":"62","author":"Ferman","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/archneur.1994.00540210060013","article-title":"Clinical-neuropathological correlations in Alzheimer's disease and related dementias","volume":"51","author":"Galasko","year":"1994","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0005-2760(89)90265-8","article-title":"Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin","volume":"1004","author":"Glanville","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib11","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1212\/WNL.53.9.2003","article-title":"Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies","volume":"53","author":"Gomez-Isla","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib12","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1093\/brain\/aws173","article-title":"Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies","volume":"135","author":"Graff-Radford","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00001756-200201210-00041","article-title":"Proton MR spectroscopic study at 3 Tesla on glutamate\/glutamine in Alzheimer's disease","volume":"13","author":"Hattori","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib15","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.57.4.626","article-title":"Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study","volume":"57","author":"Huang","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1179\/016164104225017640","article-title":"1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia","volume":"26","author":"Jones","year":"2004","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib17","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1212\/WNL.0b013e3181f073c7","article-title":"MRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathology","volume":"75","author":"Kantarci","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1212\/WNL.0b013e31826357a5","article-title":"Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies","volume":"79","author":"Kantarci","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1212\/WNL.55.2.210","article-title":"Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study","volume":"55","author":"Kantarci","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib20","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1212\/WNL.0b013e31822dc7e1","article-title":"Magnetic resonance spectroscopy, beta-amyloid load, and cognition in a population-based sample of cognitively normal older adults","volume":"77","author":"Kantarci","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib21","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.neurobiolaging.2011.09.024","article-title":"Multimodality imaging characteristics of dementia with Lewy bodies","volume":"33","author":"Kantarci","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib22","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1212\/01.WNL.0000141849.21256.AC","article-title":"1H MR spectroscopy in common dementias","volume":"63","author":"Kantarci","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib23","first-page":"843","article-title":"Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T","volume":"24","author":"Kantarci","year":"2003","journal-title":"AJNR Am. J. Neuroradiol"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0b013e31829a3329","article-title":"MRI and MRS predictors of mild cognitive impairment in a population-based sample","volume":"81","author":"Kantarci","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib25","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/archneur.1996.00550070116019","article-title":"Proton magnetic resonance spectroscopy of vascular- and Alzheimer-type dementia","volume":"53","author":"Kattapong","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib26","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s007020070051","article-title":"Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids","volume":"107","author":"Klein","year":"2000","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib27","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2967\/jnumed.109.065870","article-title":"The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies","volume":"50","author":"Lim","year":"2009","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10334-003-0004-x","article-title":"Reduced glutamate neurotransmission in patients with Alzheimer's disease \u2013 an in\u00a0vivo (13)C magnetic resonance spectroscopy study","volume":"16","author":"Lin","year":"2003","journal-title":"Magma"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1148\/radiology.198.2.8596863","article-title":"Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging","volume":"198","author":"MacKay","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib30","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib31","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1148\/radiology.187.2.8475286","article-title":"Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy","volume":"187","author":"Miller","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000065520","article-title":"Proton magnetic resonance spectroscopy in dementia with Lewy bodies","volume":"48","author":"Molina","year":"2002","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib34","article-title":"In dementia with Lewy bodies, rapid eye movement sleep behavior disorder is associated with reduced Alzheimer's disease pathology and hippocampal atrophy","volume":"8","author":"Murray","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib35","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","article-title":"Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study","volume":"10","author":"Murray","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib36","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1523\/JNEUROSCI.5612-09.2010","article-title":"Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1","volume":"30","author":"Oz","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/(SICI)1522-2594(199902)41:2<276::AID-MRM10>3.0.CO;2-8","article-title":"In\u00a0vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging","volume":"41","author":"Pfefferbaum","year":"1999","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000115751","article-title":"The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics","volume":"30","author":"Roberts","year":"2008","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib39","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S1052-5149(25)00541-6","article-title":"In\u00a0vivo MR spectroscopy of human dementia","volume":"8","author":"Ross","year":"1998","journal-title":"Neuroimaging Clin. N. Am."},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib40","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.neurobiolaging.2009.05.002","article-title":"Reduced hippocampal glutamate in Alzheimer disease","volume":"32","author":"Rupsingh","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib41","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1522-2586(199905)9:5<711::AID-JMRI14>3.0.CO;2-3","article-title":"Aging of the adult human brain: in\u00a0vivo quantitation of metabolite content with\u00a0proton magnetic resonance spectroscopy","volume":"9","author":"Saunders","year":"1999","journal-title":"J.\u00a0Magn. Reson. Imaging"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib42","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib43","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/WNL.58.6.928","article-title":"Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD","volume":"58","author":"Schuff","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib44","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/mrm.1119","article-title":"Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging","volume":"45","author":"Schuff","year":"2001","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib45","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1212\/WNL.56.5.592","article-title":"Magnetic resonance spectroscopy in AD","volume":"56","author":"Valenzuela","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/mrm.1910310404","article-title":"Automated single-voxel proton MRS: technical development and multisite verification","volume":"31","author":"Webb","year":"1994","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0197-0186(85)90127-5","article-title":"Autocannibalism of choline-containing membrane phospholipids in the pathogenesis of Alzheimer's disease","author":"Wurtman","year":"1985","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1552-6569.2007.00203.x","article-title":"Proton magnetic resonance spectroscopy detects a relative decrease of N-acetylaspartate in the hippocampus of patients with dementia with Lewy bodies","volume":"18","author":"Xuan","year":"2008","journal-title":"J.\u00a0Neuroimaging Official J. Am. Soc. Neuroimaging"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib49","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/jnnp.71.5.583","article-title":"A\u00a0clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies","volume":"71","author":"Yoshita","year":"2001","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.01.001_bib50","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ageing\/afi190","article-title":"A\u00a0systematic review of prevalence and incidence studies of dementia with Lewy bodies","volume":"34","author":"Zaccai","year":"2005","journal-title":"Age Ageing"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:42:20Z","timestamp":1746099740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458014000025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0197458014000025"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.01.001","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}